Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 8Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Skin Neoplasms 1Sexual Dysfunction, Physiological 1Recurrence 1Eunuchism 1Erectile Dysfunction 1

Interventions

Surveys and Questionnaires 5Blood Specimen Collection 3Spectrum Analysis, Raman 2Observation 2Mohs Surgery 2Microscopy, Confocal 2Intravital Microscopy 2Immunotherapy 2Dermoscopy 2Biopsy 2trametinib 1teriflunomide 1sonidegib 1pembrolizumab 1dabrafenib 1Workplace 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Specimen Handling 1Solid Phase Microextraction 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Natalizumab 1Molecular Diagnostic Techniques 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Skin Neoplasms × dabrafenib × Clear all
NCT07092670 2025-09-05

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Intergruppo Melanoma Italiano

Recruiting
270 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡